Schmid HP - Search Results

1

Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff JM, Zattoni F; EAU Working Group on Oncological Urology. Aus G, et al. Among authors: schmid hp. Eur Urol. 2001 Aug;40(2):97-101. doi: 10.1159/000049758. Eur Urol. 2001. PMID: 11528184

2

Clinical observations on the doubling time of prostate cancer.

Schmid HP, McNeal JE, Stamey TA. Schmid HP, et al. Eur Urol. 1993;23 Suppl 2:60-3. doi: 10.1159/000474708. Eur Urol. 1993. PMID: 7685704

3

The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

Stamey TA, Ferrari MK, Schmid HP. Stamey TA, et al. Among authors: schmid hp. J Urol. 1993 Dec;150(6):1856-9. doi: 10.1016/s0022-5347(17)35914-1. J Urol. 1993. PMID: 7693982 Free article.

4

[Epidemiologic observations on prostate cancer based on tumor volumes].

Schmid HP, Freiha FS, McNeal JE, Stamey TA. Schmid HP, et al. Helv Chir Acta. 1993 Dec;60(3):355-8. Helv Chir Acta. 1993. PMID: 8119814 German.

5

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L. Schmid HP, et al. Urology. 1996 May;47(5):699-703. doi: 10.1016/s0090-4295(96)00018-0. Urology. 1996. PMID: 8650868 Clinical Trial.

6

Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy.

Schmid HP, Mihatsch MJ, Hering F, Rutishauser G. Schmid HP, et al. Eur Urol. 1997;31(1):11-6. doi: 10.1159/000474411. Eur Urol. 1997. PMID: 9032528

7

Neoadjuvant hormonal therapy in radical prostatectomy and radiation-treated patients.

Schmid HP, Semjonow A, Aus G, Hertle L. Schmid HP, et al. Urol Int. 2000;65(2):63-7. doi: 10.1159/000064841. Urol Int. 2000. PMID: 11025425 Review.

8

Active monitoring (deferred treatment or watchful waiting) in the treatment of prostate cancer. A review.

Schmid HP, Adolfsson J, Aus G. Schmid HP, et al. Eur Urol. 2001 Nov;40(5):488-94. doi: 10.1159/000049824. Eur Urol. 2001. PMID: 11752854 Review.

9

Prostate specific antigen doubling time as auxiliary end point in hormone refractory prostatic carcinoma.

Schmid HP, Morant R, Bernhard J, Maibach R; Swiss Group for Clinical Cancer Research (SAKK). Schmid HP, et al. Eur Urol. 2003 Jan;43(1):28-30. doi: 10.1016/s0302-2838(02)00539-0. Eur Urol. 2003. PMID: 12507540

10

Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?

Oberpenning F, Hetzel S, Weining C, Brandt B, De Angelis G, Heinecke A, Lein M, Fornara P, Schmid HP, Hertle L, Semjonow A. Oberpenning F, et al. Among authors: schmid hp. Eur Urol. 2003 May;43(5):478-84. doi: 10.1016/s0302-2838(03)00095-2. Eur Urol. 2003. PMID: 12705990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters